1.714
前日終値:
$1.73
開ける:
$1.72
24時間の取引高:
115.74K
Relative Volume:
0.14
時価総額:
$122.17M
収益:
-
当期純損益:
$-117.50M
株価収益率:
-0.7142
EPS:
-2.4
ネットキャッシュフロー:
$-114.31M
1週間 パフォーマンス:
-8.34%
1か月 パフォーマンス:
-28.28%
6か月 パフォーマンス:
+0.82%
1年 パフォーマンス:
-29.75%
Nkarta Inc Stock (NKTX) Company Profile
名前
Nkarta Inc
セクター
電話
(925) 407-1049
住所
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NKTX
Nkarta Inc
|
1.72 | 122.88M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.16 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.66 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.79 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
919.01 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
197.41 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | 開始されました | Rodman & Renshaw | Buy |
| 2024-08-14 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-28 | 開始されました | Needham | Buy |
| 2022-07-18 | 開始されました | SVB Leerink | Outperform |
| 2022-03-11 | 開始されました | Raymond James | Outperform |
| 2022-03-08 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-06 | 開始されました | William Blair | Outperform |
| 2021-11-18 | 開始されました | SMBC Nikko | Outperform |
| 2021-07-16 | 開始されました | Oppenheimer | Outperform |
| 2020-08-04 | 開始されました | Cowen | Outperform |
| 2020-08-04 | 開始されました | Evercore ISI | Outperform |
| 2020-08-04 | 開始されました | Mizuho | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Nkarta Inc (NKTX) 最新ニュース
How interest rate cuts could boost Nkarta Inc. stockMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
Why Nkarta Inc. stock appeals to dividend seekers2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Using Python tools to backtest Nkarta Inc. strategiesWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Will Nkarta Inc. stock split again soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
How Nkarta Inc. stock benefits from strong dollarOil Prices & Reliable Trade Execution Plans - newser.com
A better buy-in window may exist right now for Nkarta Inc (NKTX) - Setenews
What momentum indicators show for Nkarta Inc. stockTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Is it time to cut losses on Nkarta Inc.Product Launch & Comprehensive Market Scan Reports - newser.com
Will Nkarta Inc. stock deliver strong dividend growthSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Nkarta, Inc.Common Stock (NQ: NKTX - FinancialContent
Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Nkarta reports Q3 EPS (29c), consensus (30c) - MSN
Nkarta Inc. stock prediction for this weekJuly 2025 Summary & Daily Price Action Insights - newser.com
Will Nkarta Inc. stock beat EPS estimatesPortfolio Risk Report & Safe Entry Zone Tips - newser.com
Published on: 2025-11-14 17:50:20 - newser.com
What is William Blair’s Forecast for Nkarta FY2025 Earnings? - Defense World
Q1 Earnings Estimate for Nkarta Issued By Leerink Partnrs - Defense World
William Blair Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World
FY2025 EPS Estimates for Nkarta Lifted by Leerink Partnrs - Defense World
Published on: 2025-11-13 17:41:50 - newser.com
Risk adjusted return profile for Nkarta Inc. analyzedWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
HC Wainwright Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World
Nkarta CEO Paul Hastings sells $38,231 in stock - MSN
Nkarta price target lowered to $11 from $12 at Stifel - MSN
Nkarta (NKTX) Receives a Buy from H.C. Wainwright - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF) - The Globe and Mail
Published on: 2025-11-12 02:36:29 - newser.com
Nkarta (NKTX) Upgraded to Buy: Here's Why - MSN
Nkarta Inc (NKTX) is looking forward to a strong quarter - Setenews
Stifel lowers Nkarta stock price target to $11 from $12, keeps Buy rating - Investing.com Canada
Nkarta Inc (NKTX) 財務データ
収益
当期純利益
現金流量
EPS
Nkarta Inc (NKTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shook David | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
8,638 |
19,004 |
190,955 |
| Levin Alyssa | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
5,838 |
12,844 |
102,662 |
| Brandenberger Ralph | Chief Technical Officer |
Jan 15 '25 |
Sale |
2.20 |
7,447 |
16,383 |
124,796 |
| HASTINGS PAUL J | Chief Executive Officer |
Jan 15 '25 |
Sale |
2.20 |
17,378 |
38,232 |
319,859 |
| Hager Alicia J. | Chief Legal Officer |
Jan 15 '25 |
Sale |
2.20 |
9,584 |
21,085 |
146,735 |
大文字化:
|
ボリューム (24 時間):